Commercial Hit List
Who should EDx engage next—and why?
One work queue for Circle/Spire discovery and HCA uptake opportunities: priority, offering, why engage, owner, status and the next action.
- P2· Qualify· Illustrative Circle accountCircle Illustrative data
Caris MI Profile · Circle/Spire discovery
Specialty & focus: Medical Oncology · Lung and thoracic cancers
Why engage: Two oncologists account for 50 relevant tissue-profiling orders, mainly with Tempus and Foundation Medicine. The thoracic oncologist drives most of the activity; ordering access is still to confirm. Messaging: Discuss how MI Profile’s DNA, RNA and protein assessment relates to thoracic profiling from limited tissue, and explain the ordering process.
Next: Prioritise this contact for a profiling discussion. Tailor the conversation to their current provider-choice criteria and the relevant capabilities of Caris MI Profile.
- P2· Qualify· Illustrative Circle accountCircle Illustrative data
Caris Assure · Circle/Spire discovery
Specialty & focus: Medical Oncology · Thoracic cancers
Why engage: A thoracic oncologist orders blood-based profiling for advanced cases where tissue biopsy is not feasible. Messaging: Discuss blood-based profiling requirements in tissue-limited cases and how Caris Assure helps interpret tumour-derived versus blood-cell-derived signals.
Next: Arrange a focused discussion around suitable tissue-limited cases.
- P2· Qualify· Illustrative HCA accountHCA Illustrative data
Caris MI Profile · HCA uptake
Specialty & focus: Medical Oncology · Gastrointestinal cancers
Why engage: Limited EDx usage in this example creates a reason to investigate current test-selection criteria and identify suitable opportunities. Messaging: Discuss how MI Profile’s DNA, RNA and protein assessment relates to this physician’s GI profiling requirements, and explain the ordering process.
Next: Schedule a follow-up around suitable cases and the account’s decision criteria.
- P2· Qualify· Illustrative Spire account BSpire Illustrative data
M371 · Circle/Spire discovery
Specialty & focus: Medical Oncology · Testicular / germ-cell cancers
Why engage: A testicular-cancer oncologist manages diagnosis and follow-up using classical serum markers, creating a clear M371 discussion. Messaging: Discuss where M371 adds to classical markers at diagnosis and in surveillance, and how it fits the existing follow-up schedule.
Next: Arrange a focused product discussion on the diagnostic and follow-up pathway.
Mark existing EDx relationships
Match supplied names to identify existing contacts or accounts already being pursued. This organises the queue only — it does not indicate ordering, EDx usage or priority.
Changes are saved in this browser only; they do not sync between team members.